Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 439 000 KRW 4.15% Market Closed
Market Cap: 23.4T KRW
Have any thoughts about
Alteogen Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

-1 336
Current
-65.4
Median
3.8
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-1 336
=
Enterprise Value
23.2T KRW
/
FCFF
-17.3B KRW
All Countries
Close
Market Cap EV/FCFF
KR
Alteogen Inc
KOSDAQ:196170
23.3T KRW -1 336
FR
Pharnext SCA
OTC:PNEXF
6T USD -235 459.5
US
Abbvie Inc
NYSE:ABBV
300.2B USD 22.5
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD -84.3
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -476.4
AU
CSL Ltd
ASX:CSL
137.3B AUD 65.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 24.3
US
Seagen Inc
F:SGT
39.3B EUR -57.5
NL
argenx SE
XBRU:ARGX
34.1B EUR -101.2
 
KR
Alteogen Inc
KOSDAQ:196170
Average EV/FCFF: 31.2
Negative Multiple: -1 336
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -235 459.5
US
Abbvie Inc
NYSE:ABBV
22.5
US
Amgen Inc
NASDAQ:AMGN
32.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -84.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -476.4
AU
CSL Ltd
ASX:CSL
65.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
24.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -101.2

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More